Electroceutical Devices Global Market

Forecast to 2022

Electroceutical Devices Global Market estimated to be worth $44.3 billion by

2022
IQ4I Research & Consultancy published a new report on Electroceutical Devices
Global Market Forecast To 2022 This report analyzes and studies the overall market,
major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific
and Rest of the World
IQ4Is Report Contains 192 market data tables and 92 figures spread through 492
pages
and an exhaustive
TOC
on Electroceutical
Devices
Global
Market [TECHNOLOGY {Internal Electroceuticals (SCS, DBS, VNS, SNS, ICDs, EAS,
GES, RES & Internal Pacemakers) and External Electroceuticals (TENS, External
Pacemakers, External Defibrillators, TTFields and Micro Current)}, APPLICATION
(Pain Management, CNS, Gastroenterology & Urology, Cardiology, Otology and
Others), END USERS (Hospitals and Home Care), REGION (North America, Europe,
Asia-Pacific and Rest of the World)]
This report analyzes the Electroceutical Devices global market in terms of market revenue ($
million) for all segments and it enables Electroceutical Devices market stakeholders such as
Payers (Insurance companies, Government insurance providers), Providers (Hospitals and
Physicians), Electroceutical devices manufacturers, Electroceutical devices distributors and
wholesalers, OEM (Original Equipment Manufacturers)/contract manufacturers, Hospitals
and Home-care providers, Group Purchasing Organizations (GPOs) in Electroceutical
Devices global market.

Electroceuticals are medical devices which make use of electrical impulse to stimulate
nerves and tissue to relieve or alleviate various conditions of the body. Electroceuticals are
emerging as an alternative to pharmaceuticals as they are highly target specific and affect
the body electrically rather affecting the chemistry of body, in case of the use of pills which in
turn leads to various side effects. The electroceutical devices market is expanding at a
steady rate. The electroceutical devices global market is expected to grow at a high CAGR
to reach $44,336 million in 2022. Growing prevalence of medical conditions related to central
nervous system for e.g. Parkinson, depression etc, increase in aging population prone to
chronic medical conditions, increase in research and development investments for
electroceutical and cost effectiveness of the therapy are driving the market growth.
According to World Health Organization (WHO), the worlds population of over 60 years is
estimated to increase from 12% of overall population in 2015 to about 22% by 2050 and it is
projected that by 2020, the aged group will outnumber children younger than 5 years this
due to rising life expectancy and falling birth rates.
IQ4I Research & Consultancy Pvt. Ltd.

Page 1

Electroceutical Devices Global Market

Forecast to 2022

However, the electroceutical devices are clunky & imprecise, the use needs shocking large
areas of neural tissue to stimulate the desired response and mode of action is still a trail &
error method are the factors hindering the growth of the market. The lack of self regulating
measurement, miniaturization in terms of electrodes or chip which can interface with single
nerve and the devices must be wireless with elimination of traditional batteries are some of
the challenges faced by electroceutical market.
The electroceutical devices global market is segmented into internal and external
electroceutical devices based on the type. The Internal electroceutical devices are designed
to deliver electrical currents through an electrode (leads) that are placed inside the body
through traditional or minimally invasive procedures. External electroceutical is another type
of neuromodulation/neurostimulation where the stimulation device are either placed or
moved at specific locations over the body to deliver therapy.
The internal electroceutical segment held the largest market revenue in 2015 and is
expected to grow by 2022 growing at a high CAGR from 2015 to 2022 due to technological
advancement in wireless micro current stimulation, wearable pain management technology,
miniaturization etc.
The internal electroceutical devices is again classified into Spinal Cord Stimulation (SCS),
Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation
(SNS) and others which includes Gastric Electric Stimulation (GES), Respiratory Electrical
Stimulation (RES), cardiac pacemakers, Implantable Cardioverter Defibrillator (ICD),
cochlear implants. External electroceutical devices are classified as Transcutaneous
Electrical Nerve Stimulation (TENS), External Pacemakers, External Defibrillators and others
based on technology.

Based on the application the electroceutical devices market is segmented into pain
management, central nervous system, gastroenterology & Urology, hearing aids, cardiology
and others. Based on end-users the market is segmented into hospitals and home-care.
Among end-users, hospitals held the largest revenue in 2015 and are expected to growth at
a high CAGR from 2015 to 2022.

The electroceutical devices global market based on geography is divided into North America,
Europe, Asia-Pacific and Rest of the world. North American region commanded the largest
revenue market expected to grow at a moderate CAGR. Favourable reimbursement
IQ4I Research & Consultancy Pvt. Ltd.

Page 2

Electroceutical Devices Global Market

Forecast to 2022

coverage and high investments in healthcare infrastructures have led the market growth in
this region. However, Asia- Pacific region is expected to grow at the highest CAGR 2015 to
2022 due to increased healthcare awareness, improved economic growth and increasing
government funding, large patient pool and rising aged population with increased surgeries.

The existing demerits of pharmaceuticals have paved the way for development
electroceuticals which affect the body electrically and are highly target specific. Investment in
research and development plays a significant role in the growth of devices or products.
British drug Maker Company GSK (GlaxoSmithKline) a pharmaceutical giant has invested
$50 million in its action potential venture fund on five start-ups companies for conducting
research on electroceutical and $5 million for its own Bioelectronic research centre at GSK
and has forged collaborations with 40 research universities. GSK has funded approximately
33 electroceuticals that are mostly in early research stages. GSK currently has early
prototypes in animal testing and plans to start human trials using third-party devices in 2017
and planning to begin its own electroceutical devices by 2019. Recently in August 2016 GSK
and Google spinoff Verily Life Sciences entered a joint venture to form Galvani
Bioelectronics that will work on research, development and commercialisation of
bioelectronic or electroceutical devices. GSK and Verily Life Sciences would provide funding
close to $715 million over 7 years. Initial research is concentrated on treating inflammatory,
metabolic and endocrine disorders, type 2 diabete and disease caused by zapping nerves.
National Institute of Health (NIH) of U.S is investing heavily in development of
electroceuticals. NIH has announced funds of $248 million for development of
electroceuticals.

In the coming years, the technological advancements such as introduction of organ

regeneration apart from tissue regeneration for treating wound care, multi point pacing
technology, wireless micro-current stimulation, wearable devices and miniaturized devices
would change the therapeutic approach of electroceutical device use.

Major players in electroceutical devices market include Medtronic (Ireland), Boston Scientific
(U.S.), LivaNova (U.S.), St. Jude Medical (U.S.), NeuroMetrix, Inc (U.S.), Nevro Corporation
(U.S.), DJO Global (U.S.), Enteromedics (U.S.), Biotronik (Germany), Philips (Netherland)
and Cochlear Ltd (Australia).

IQ4I Research & Consultancy Pvt. Ltd.

Page 3

Electroceutical Devices Global Market

Forecast to 2022

Reasons for buying this report:

Analysis of the Electroceutical Devices global market by identifying various segments

by type, end-users and geography.

Revenue forecast of the Electroceutical Devices market and strategic analysis of

each submarket with respect to segmental growth trends.

Analysis of the major market trends and factors driving or inhibiting the growth of the
Electroceutical Devices global market.

Revenue forecast of the Electroceutical Devices market with respect to North

America, Europe, Asia-Pacific and the Rest of the World (RoW) regions.

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market.

Market share analysis of key players in Electroceutical Devices, details of their

product offerings, revenues, business strategies and SWOTs

Established and Emerging players (89 companies) and their product offerings.

IQ4I Research & Consultancy Pvt. Ltd.

Page 4

Electroceutical Devices Global Market

Forecast to 2022

FIGURE 1
ELECTROCEUTICAL DEVICES GLOBAL MARKET SEGMENTATION

Electroceutical Devices Global Market

By Technology

Internal
Electroceutical
devices

External
Electroceutical
devices

SCS

TENS

DBS

External
Pacemakers

VNS
SNS

External
Defibrillators

Pacemakers

Others

By Applications

By End-Users

By Region

Pain Management

Hospitals

NA

Home Care

EU

CNS
Gastroenterology/
Urology

APAC
RoW

Hearing aids
Cardiology
Others

ICD

Cochlear Implants
Others

IQ4I Research & Consultancy Pvt. Ltd.

Page 5